Januvia Generics Arrive In India
MSD Defends Its Turf As Sitagliptin Looks To Unseat Teneligliptin, Vildagliptin
A wave of cut-price sitagliptin generics is seen hitting the Indian market with expiry of the patent on Merck’s Januvia, a product that has had a hugely eventful journey over the years including fending off pre-expiry challengers. Will the originator respond with price cuts?
